Jazz Pharmaceuticals (JAZZ)
NASDAQ: JAZZ
· Real-Time Price · USD
119.05
-0.15 (-0.13%)
At close: Aug 20, 2025, 3:37 PM
119.07
0.02%
After-hours: Aug 20, 2025, 04:04 PM EDT
Jazz Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -718.47M | -92.54M | 191.12M | 215.06M | 168.57M | -14.62M | 94.15M | 146.82M | 104.44M | 69.42M | -240.72M | -19.65M | 34.66M | 1.65M | -35.35M | -52.83M | -363.32M | 121.83M |
Depreciation & Amortization | 174.01M | 164.87M | 168.42M | 165.23M | 163.03M | 163.38M | 159.2M | 162.56M | 159.58M | 157.36M | 144.73M | 148.83M | 156.2M | 179.71M | 164.62M | 167.58M | 147.31M | 72.97M |
Stock-Based Compensation | 64.5M | 67.65M | 70.19M | 59.76M | 56.65M | 61.44M | 52.94M | 56.12M | 61.43M | 56.35M | 61.56M | 56.68M | 53.69M | 50.07M | 53.12M | 53.24M | 48.16M | 34.48M |
Other Working Capital | -238.34M | 238.34M | -59M | n/a | -46.23M | 97.28M | -96.04M | -11M | -3.55M | -38.16M | 119.69M | 58.92M | -524K | 21.46M | -43.02M | 56.79M | -16.39M | 39.25M |
Other Non-Cash Items | 923.14M | 45.73M | 51.15M | 52.7M | 45.08M | 67.01M | 77.95M | 45.17M | 67.86M | 85.31M | 462.96M | 226.98M | 128.61M | 63.58M | 107.68M | 122.03M | 91.19M | 24.54M |
Deferred Income Tax | -66.42M | -43.83M | -2.35M | -64.4M | -75.18M | -66.39M | -35.9M | -78.92M | -79.33M | -66.06M | -145.38M | -64.56M | -36.98M | -45.34M | -27.39M | -74.99M | 190.7M | -19.11M |
Change in Working Capital | -287.9M | 287.9M | -79.93M | -29.59M | -26.81M | 56.4M | -181.01M | -24.55M | -17.21M | 18.32M | 58.83M | 69.71M | -77.94M | -40.69M | -84.92M | 59.04M | -72.35M | 50.28M |
Operating Cash Flow | 88.86M | 429.78M | 398.58M | 398.75M | 331.35M | 267.23M | 167.34M | 307.19M | 296.76M | 320.71M | 341.97M | 417.99M | 303.04M | 208.98M | 177.75M | 274.06M | 41.7M | 285M |
Capital Expenditures | 12.03M | -38.88M | -13.29M | -10.79M | -7.09M | -6.9M | -10.1M | -4.3M | -5.74M | -4.82M | -384.38M | 4.9M | -81.43M | -37.29M | -9.97M | -26.22M | -7.18M | -2.17M |
Cash Acquisitions | -858.05M | n/a | n/a | n/a | n/a | n/a | 20M | -20M | n/a | n/a | n/a | n/a | 53M | n/a | -6.23B | n/a | -6.23B | 20.7M |
Purchase of Investments | 440.05M | -440.05M | -470M | 705M | -330M | -375M | -120.1M | -190M | -80M | n/a | 61.04M | -300K | -60.74M | n/a | -125K | -594K | -5.4M | -20.7M |
Sales Maturities Of Investments | 470M | 310M | 290M | 355M | 80M | 120M | 250M | 20M | n/a | n/a | 60M | n/a | n/a | n/a | 26.82M | n/a | 335M | 760M |
Other Investing Acitivies | -680.05M | -25M | n/a | -835.13M | n/a | -10M | -38M | 20M | -80M | -1M | -61.04M | -300K | -76.88M | -25M | 6.21B | -18.48M | -6.23B | -20.7M |
Investing Cash Flow | -641.02M | -168.93M | -193.29M | 214.09M | -257.09M | -271.9M | 101.8M | -174.3M | -85.74M | -4.82M | -324.38M | 4.6M | -89.16M | -37.29M | -10.09M | -26.81M | -5.91B | 737.13M |
Debt Repayment | n/a | -757.75M | -7.75M | 398.02M | -7.75M | -7.75M | -7.75M | -7.75M | -7.75M | -7.75M | -7.75M | -307.75M | -7.75M | -258.76M | -258.76M | -477.57M | 4.62B | -8.35M |
Common Stock Repurchased | n/a | n/a | 360.73M | -150M | -161.43M | -49.3M | -99.8M | -74.37M | -95.59M | -43.27M | -2.81M | -2.57M | -6.34M | -33.78M | -6M | -2.43M | -3.39M | -23.78M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | -112.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 633.23M | -55.72M | -301.01M | 396.43M | -2.85M | -48.8M | 110.67M | 3.63M | -4.19M | -22.04M | 27.35M | 18.69M | 18.53M | -12.05M | 12.15M | 12.39M | 48.49M | 26.62M |
Financial Cash Flow | -124.53M | -813.47M | -8.28M | 246.43M | -161.09M | -56.55M | -100.31M | -78.49M | -96.67M | -29.79M | 19.6M | -289.05M | 10.78M | -270.81M | -246.61M | -465.18M | 4.66B | 18.28M |
Net Cash Flow | -672.07M | -550.92M | 194.73M | 862.33M | -87.58M | -62.92M | 170.62M | 53.39M | 114.39M | 286.43M | 42.12M | 128.09M | 220.43M | -100.61M | -80.33M | -219.62M | -1.21B | 1.04B |
Free Cash Flow | 100.89M | 390.9M | 385.29M | 387.96M | 324.26M | 260.32M | 157.24M | 302.9M | 291.03M | 315.89M | -42.41M | 422.89M | 221.61M | 171.69M | 167.79M | 247.84M | 34.52M | 282.83M |